Leuprolide

Leuprolide

SCHEMBL4414320

CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1.C[S+](C)[O-]

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GNRHR

The experimentally established mechanism targets of Leuprolide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GNRHR known ✓ P30968 2/20 0.82
ABCC2 Q92887 1/20 0.84
PTGS1 P23219 1/20 0.75
APLNR P35414 5/20 0.63
CXCR4 P61073 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Leuprolide SCHEMBL2428076 0.99 GNRHR (0.84) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL570851 0.98 ABCC2 (0.87) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL177978 0.98 ABCC2 (0.87) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL3174 0.98 ABCC2 (0.87) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL847084 0.98 ABCC2 (0.87) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL7751433 0.97 GNRHR (0.86) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL10061885 0.97 GNRHR (0.86) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL21540132 0.97 GNRHR (0.86) ABCC2GNRHRPTGS1APLNRCXCR4
Leuprolide SCHEMBL4585 0.97 GNRHR (0.86) ABCC2GNRHRPTGS1APLNRCXCR4
Deslorelin SCHEMBL1649660 0.97 GNRHR (0.86) ABCC2GNRHRPTGS1APLNRCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660039-A4 PREVENTION OF MOLECULAR WEIGHT REDUCTION OF THE POLYMER, IMPURITY FORMATION AND GELLING IN POLYMER COMPOSITIONS OAKWOOD LAB L L C (US) 2009-08-12 EP disclosed
EP-1660039-A2 PREVENTION OF MOLECULAR WEIGHT REDUCTION OF THE POLYMER, IMPURITY FORMATION AND GELLING IN POLYMER COMPOSITIONS Oakwood Laboratories L.L.C. (US) 2006-05-31 EP disclosed
EP-1610761-A2 OSMOTIC DELIVERY SYSTEM AND METHOD FOR DECREASING START-UP TIMES FOR OSMOTIC DELIVERY SYSTEMS Alza Corporation (US) 2006-01-04 EP disclosed
WO-2005007122-A2 POLYMER STABILIZATION OAKWOOD LABORATORIES, L.L.C. (US) 2005-01-27 WO disclosed
WO-2004089334-A2 OSMOTIC DELIVERY SYSTEM AND METHOD FOR DECREASING START-UP TIMES FOR OSMOTIC DELIVERY SYSTEMS ALZA CORPORATION (US) 2004-10-21 WO disclosed